Mielcarek M - Search Results

1

Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation.

Mielcarek M, Kirkorian AY, Hackman RC, Price J, Storer BE, Wood BL, Leboeuf M, Bogunovic M, Storb R, Inamoto Y, Flowers ME, Martin PJ, Collin M, Merad M. Mielcarek M, et al. Transplantation. 2014 Sep 15;98(5):563-8. doi: 10.1097/TP.0000000000000097. Transplantation. 2014. PMID: 24717220 Free PMC article. Clinical Trial.

2

Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells.

Mielcarek M, Martin PJ, Torok-Storb B. Mielcarek M, et al. Blood. 1997 Mar 1;89(5):1629-34. Blood. 1997. PMID: 9057645 Free article.

3

Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation.

Mielcarek M, Bryant E, Loken M, Torok-Storb B, Storb R. Mielcarek M, et al. Br J Haematol. 1999 May;105(2):361-5. Br J Haematol. 1999. PMID: 10233404 Free article.

4

Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.

Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Mielcarek M, et al. Blood. 2000 Aug 1;96(3):1150-6. Blood. 2000. PMID: 10910936 Free article.

5

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.

Mielcarek M, Sandmaier BM, Maloney DG, Maris M, McSweeney PA, Woolfrey A, Chauncey T, Feinstein L, Niederwieser D, Blume KG, Forman S, Torok-Storb B, Storb R. Mielcarek M, et al. J Clin Immunol. 2002 Mar;22(2):70-4. doi: 10.1023/a:1014532401666. J Clin Immunol. 2002. PMID: 11998895 Review.

6

ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia.

Mielcarek M, Torok-Storb B, Storb R. Mielcarek M, et al. Bone Marrow Transplant. 2002 Oct;30(8):547-8; author reply 548. doi: 10.1038/sj.bmt.1703706. Bone Marrow Transplant. 2002. PMID: 12379898 No abstract available.

7

Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.

Maciej Zaucha J, Mielcarek M, Takatu A, Little MT, Gooley T, Baker J, Maloney DG, Sandmaier BM, Maris M, Chauncey T, Storb R, Torok-Storb B. Maciej Zaucha J, et al. Among authors: mielcarek m. Br J Haematol. 2002 Dec;119(3):740-50. doi: 10.1046/j.1365-2141.2002.03905.x. Br J Haematol. 2002. PMID: 12437653 Free article.

8

Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?

Awaya N, Baerlocher GM, Manley TJ, Sanders JE, Mielcarek M, Torok-Storb B, Lansdorp PM. Awaya N, et al. Among authors: mielcarek m. Biol Blood Marrow Transplant. 2002;8(11):597-600. doi: 10.1053/bbmt.2002.v8.abbmt080597. Biol Blood Marrow Transplant. 2002. PMID: 12463478 Review.

9

Is alloantigen expression by host epithelium required for acute graft-versus-host disease?

Mielcarek M, Torok-Storb B, Storb R. Mielcarek M, et al. Nat Med. 2003 Feb;9(2):150-1; author reply 151. doi: 10.1038/nm0203-150. Nat Med. 2003. PMID: 12563319 No abstract available.

10

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM, Maris MB, Storb R. Mielcarek M, et al. Blood. 2003 Jul 15;102(2):756-62. doi: 10.1182/blood-2002-08-2628. Epub 2003 Mar 27. Blood. 2003. PMID: 12663454 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters